NRGHN015
OPEN TO ACCRUAL
PII Chemo carbo+pac or CIT carbo+pac+cemi PD-L1 in Squamous Carcinoma HN with Salvage Neopolis
UW25009
OPEN TO ACCRUAL
Identifying biomarkers of oral cancer response to neoadjuvant immunotherapy prior to surgery
UW25107
OPEN TO ACCRUAL
FORTIFI-HN01 Ph 2,3 Study of Ficerafusp Alfa BCA101 or Placebo in Combo W Pembro for PD-L1+ HNSCC